Le Lézard
Classified in: Health
Subject: ANW

EyeCRO joins leading organizations to prioritize animal welfare in scientific research by signing the Marseille Declaration


EyeCRO is the first US-based company to sign the Declaration

OKLAHOMA CITY, Okla. and ANN ARBOR, Mich., Aug. 11, 2023 /PRNewswire-PRWeb/ -- Toward enhancing ethical practices in scientific research, EyeCRO has joined several industry-leading companies to sign the "Marseille Declaration", the first joint pharmaceutical industry declaration on animal housing and use. Through this declaration, the participating organizations affirm their dedication to the highest standards of animal welfare, transcending any competitive boundaries for the betterment of research practices.

EyeCRO is the first US-based company to sign and joins the Merck KGaA Darmstadt Germany, Novo Nordisk, Novartis, Sanofi, Lundbeck, and Leo Pharma by signing the Declaration.

"We are not competitors when it comes to improving animal welfare, and this commitment demonstrates our shared common values and expectations. This partnership allows for transparent discussion to develop the highest standards in the true spirit of scientific collaboration," stated Dr. Eric Phelps, Vice President of Research and Development.

The Marseille Declaration's mission extends beyond scientific advancements to prioritize the well-being of animals involved in research endeavors. By signing this declaration, these renowned institutions which have long been at the forefront of scientific discovery, commit to sharing their best practices, knowledge, and resources to enable the more ethical and humane treatment of animals.

"Animal welfare is of paramount importance, and this declaration reflects our belief that a better future for scientific research lies in collaboration and unity. Together we prioritize animal welfare, recognizing that our combined expertise and resources will lead the way for the highest standards in animal science and welfare. This declaration reaffirms our commitment and determination to maintain a culture that upholds the values of compassion and respect for all living beings," said Dr. Rafal Farjo, Chief Executive Officer.

The declaration outlines a comprehensive framework that emphasizes transparency, responsible animal care, and continuous improvement. It underscores the importance of minimizing the use of animals in research whenever possible and seeks to enhance alternatives that contribute to the refinement, reduction, and replacement of animal use. The institutions involved in this collaborative effort are paving the way for a more compassionate and ethically driven approach to scientific research. By aligning their efforts and expertise, they aim to set new benchmarks for animal welfare and lead by example for the broader scientific community.

About EyeCRO

EyeCRO is the global leader in preclinical ophthalmic research to advance therapeutic discovery and development programs. The company operates laboratories in Oklahoma City, OK and Ann Arbor, MI, which provide validated contract research services to the ophthalmic research community worldwide.

Pull Quote

"We are not competitors when it comes to improving animal welfare, and this commitment demonstrates our shared common values and expectations."

Media Contact

Media Relations, EyeCRO, 1 4056048954, [email protected], www.EyeCRO.com

Twitter, LinkedIn

 

SOURCE EyeCRO


These press releases may also interest you

at 10:48
Glytec, whose industry leading SaaS platform empowers collaborative diabetes management and insulin dosing from the hospital to the home, announces a major step forward in its advocacy and partnership efforts to drive excellence in diabetes care and...

at 10:47
Swaggerty's Farm earns the Award of Merit for Meat Institute's 2023 Worker Safety Recognition Award Program. Moving up two award levels from the previous year, the Award of Merit is the second highest level of awards given. ...

at 10:38
Future Health, a leading innovator in healthcare solutions, and the innovative force behind Done, a platform that allows users to manage their ADHD, today announced its initiative aimed at alleviating clinician burnout. Its Psychiatric Collaborative...

at 10:37
Pvolve, the fitness franchise that pairs low-impact, functional movement with resistance equipment to build strong, mobile bodies, announced the largest franchise deal in the company's history. The agreement is for five studio locations across...

at 10:36
Once Upon a Coconut, a leading provider of premium coconut water, is pleased to announce the appointment of Gary Brecka as the new Chair of its Health and Wellness Board. With his extensive experience in the industry and commitment to promoting...

at 10:35
GE HealthCare today announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which comprehensively integrate artificial intelligence (AI), advanced tools and an ergonomic design to speed exam time for clinicians while delivering a...



News published on and distributed by: